tiprankstipranks
Trending News
More News >
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market

ENDRA Life Sciences (NDRA) Income Statement

Compare
852 Followers

ENDRA Life Sciences Income Statement

Last quarter (Q3 2025), ENDRA Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ENDRA Life Sciences's net income was $-1.60M. See ENDRA Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -275.45K$ -234.26K$ -224.41K$ -165.25K
Operating Expenses
$ 10.82M$ 10.25M$ 12.92M$ 11.27M$ 11.34M
Depreciation and Amortization
$ 46.49K$ 275.45K$ 234.26K$ 224.41K$ 165.25K
EBITDA
$ -10.77M$ -9.78M$ -12.94M$ -11.01M$ -11.33M
Operating Income
$ -10.82M$ -10.52M$ -13.16M$ -11.50M$ -11.50M
Other Income/Expenses
$ -690.80K$ 460.49K$ -21.53K$ 267.06K$ -223.58K
Pretax Income
$ -11.51M$ -10.06M$ -13.18M$ -11.23M$ -11.73M
Net Income
$ -11.51M$ -10.06M$ -13.18M$ -11.23M$ -11.73M
Per Share Metrics
Basic EPS
$ -10.25$ -5.89$ -4.57$ -5.47$ -12.47
Diluted EPS
$ -10.25$ -5.89$ -6.84$ -5.47$ -12.47
Weighted Average Shares Outstanding
1.12M 1.71M 1.93M 2.05M 959.61K
Weighted Average Shares Outstanding (Diluted)
1.12M 1.71M 1.93M 2.05M 959.61K
Currency in USD

ENDRA Life Sciences Earnings and Revenue History